Investors pile in on psychedelic drugs
After years on the outer, psychedelic drugs are making a comeback as a legitimate treatment for patients with mental illness - and investors are taking notice.
Psychedelic drugs might be about to become the next medical marijuana for investors. Getty
Psychedelics are approaching a new high. After decades of being stigmatised, they are emerging as a legitimate treatment for psychiatric disorders.
They are also emerging as a legitimate new global market for investment. This may sound like an inversion of the world order, but it’s under way in several countries.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles